As a leading medical center that specializes in stem cell therapy, WSCMC provides the safest and most effective individualized treatment program with our highly experienced medical team, our advanced technology and our world-class medical care.

As a result of our treatment program, a significant improvement can be achieved within five weeks.

Our clinical applications are based on the results of stem cell research from the last ten years. The investor and founder of WSCMC, Mr. Eric Huang, is also the founder and a major investor in China's first stem cell research company, Beijing SinoCells Bio. Co., Ltd. (SinoCells) and the Stem Cell Research Center at Peking University. Since then, several research projects sponsored by the national fund (such as "863", "973" and "221" programs) for science and research have progressed to a stage of commercialization and clinical application.

Scientifically, stem cells have made it possible for currently incurable diseases to be treated, but clinically speaking, stem cells alone only have a very limited curative effect. This is the reason behind the many unsuccessful treatments using stem cells. Our core technology is a combination of using stem cells as a tool or "raw material" with our unique clinical technologies that create a most suitable internal environment to allow the auto mobilization of stem cells to occur, or the implanted stem cells to survive long enough to achieve their repairing or reconstruction effects.

The stem cells used for transplantation are all produced and processed in the SFDA certified GMP facilities and inspected through our Quality Certificate Approval System. This ensures a product containing the highest quality and level of safety.